Europe - Euronext Milan - BIT:1BMY - US1101221083 - Common Stock
We assign a fundamental rating of 6 out of 10 to 1BMY. 1BMY was compared to 55 industry peers in the Pharmaceuticals industry. 1BMY has an average financial health and profitability rating. 1BMY may be a bit undervalued, certainly considering the very reasonable score on growth Finally 1BMY also has an excellent dividend rating. This makes 1BMY very considerable for value and dividend investing!
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.23% | ||
| ROE | 32.55% | ||
| ROIC | 17.49% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.51% | ||
| PM (TTM) | 12.57% | ||
| GM | 73.15% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.41 | ||
| Debt/FCF | 3.2 | ||
| Altman-Z | 2.22 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 1.17 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.29 | ||
| Fwd PE | 8.92 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.23 | ||
| EV/EBITDA | 6.72 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.59% |
ChartMill assigns a fundamental rating of 6 / 10 to 1BMY.MI.
ChartMill assigns a valuation rating of 9 / 10 to BRISTOL-MYERS SQUIBB CO (1BMY.MI). This can be considered as Undervalued.
BRISTOL-MYERS SQUIBB CO (1BMY.MI) has a profitability rating of 6 / 10.
The financial health rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 5 / 10.
The dividend rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 8 / 10 and the dividend payout ratio is 82.81%.